The study showed that CXCR4 blocking led to reduced infiltration of monocyte-derived suppressor cells within the TIME in vivo, enhancing the sensitivity of GBM cells to radiation-induced immunogenic cell death (ICD) and triggering anti-GBM-specific immunological T-cell-mediated immunity. This evidence concerns the gene CXCR4 and glioblastoma.